The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

A drug currently used for the treatment of AIDS patients is showing promise in animal studies as a preventive, but the drug’s maker, Gilead, is keeping a low profile, based partly on fears that Truvada will be seen as a

biomedical condom

that might promote unsafe sex and lead to a backlash against a company that has become a Wall Street darling.

Comments are closed.

Of Interest